2019
DOI: 10.1111/xen.12566
|View full text |Cite
|
Sign up to set email alerts
|

Healing characteristics of acellular porcine corneal stroma following therapeutic keratoplasty

Abstract: Background: Acellular porcine corneal stroma (APCS) has proven to be a promising alternative to traditional corneal grafts. This prospective case series was conducted to further investigate the healing characteristics of APCS following keratoplasty. Methods:Twenty-seven patients undergoing APCS implantation to treat infectious keratitis were included. The patients were followed up for 12 months after surgery.The main outcome measures included visual acuity, corneal transparency, graft thickness, and cellular a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
31
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(34 citation statements)
references
References 40 publications
1
31
0
Order By: Relevance
“…Porcine corneas have been successfully used for corneal xenotransplantation over the past decade 41 . Li et al 42 reported that keratocytes started to repopulate from human recipient tissue into the acellular porcine corneal stroma between 3 and 6 months post‐operatively via proliferation and migration. The results clinically indicated that ECM components of porcine corneas encourage human keratocyte ingrowth and demonstrated good biological stability.…”
Section: Discussionmentioning
confidence: 99%
“…Porcine corneas have been successfully used for corneal xenotransplantation over the past decade 41 . Li et al 42 reported that keratocytes started to repopulate from human recipient tissue into the acellular porcine corneal stroma between 3 and 6 months post‐operatively via proliferation and migration. The results clinically indicated that ECM components of porcine corneas encourage human keratocyte ingrowth and demonstrated good biological stability.…”
Section: Discussionmentioning
confidence: 99%
“…To date, DPC was approved to be used for LKP only by the Chinese National Institutes for Food and Drug Control in 2015 ( Shi and Xie, 2016 ). Three clinical trials and one case report using DPC in China have been published; all the studies were performed using the same commercially available DPC products ( Li et al, 2019 , 2020 ; Shi et al, 2017 ; Zhang et al, 2015 ; Zheng et al, 2019 ). The DPC was decellularized by hypertonic NaCl-ultrapure water alternating treatments, preserved in glycerol, and sterilized by 60 Co irradiation ( Zheng et al, 2019 ).…”
Section: Development Of Decellularized Cornea and Efficacy Datamentioning
confidence: 99%
“…In the third clinical trial, 39 patients with progressive infectious keratitis underwent ALK using DPC for a 12 month-follow up. Twelve patients (30.8%) showed graft failure associated with herpetic keratitis and a graft size larger than 8.0 mm ( Li et al, 2019 , 2020 ). In a case report, DPC tissue was transplanted in a patient with a corneal ulcer and histology showed minimal infiltration of the inflammatory cells and migration of recipient's stromal cells.…”
Section: Development Of Decellularized Cornea and Efficacy Datamentioning
confidence: 99%
“…2,3 However, these acellular scaffolds are composed of densely packed collagen lamellae, and thus recellularization is difficult, making it slow, both in vitro 4 and in vivo. 5 In attempts to improve recellularization, human lenticules extracted during myopia correction surgeries have been attached together using a fibrin glue hydrogel to prepare a decellularized scaffold. 6 Although the decellularized lenticules did populate with a small number of cells, the phenotype of these was not characterized.…”
Section: Introductionmentioning
confidence: 99%